Journal article
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Abstract
BACKGROUND: To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods.
METHODS: We compared HPV testing, using an assay approved by the Food and Drug Administration, with conventional Pap testing as a screening method to identify high-grade cervical intraepithelial neoplasia in women ages 30 to …
Authors
Mayrand M-H; Duarte-Franco E; Rodrigues I; Walter SD; Hanley J; Ferenczy A; Ratnam S; Coutlée F; Franco EL
Journal
New England Journal of Medicine, Vol. 357, No. 16, pp. 1579–1588
Publisher
Massachusetts Medical Society
Publication Date
October 18, 2007
DOI
10.1056/nejmoa071430
ISSN
0028-4793